The effect of Hyaluronic Acid and Triamcinolone in Oral Lichen Planus
Phase 3
- Conditions
- oral lichen planus.Lichen planus
- Registration Number
- IRCT201612241559N11
- Lead Sponsor
- Private funding source
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Bilateral presence of white reticular-papular lesions; histopathological criteria such as hydropic (liquefactive) degeneration of basal layer; band-like infiltration of mononuclear inflammatory cells in the superficial connective tissue; erosive/ulcerative form of lesion and atrophic/erythematous form of lesion.
Exclusion criteria: Dysplasia; systemic diseases; history of chemotherapy; history of radiotherapy; pregnancy and nursing; history of allergy to hyaluronic acid
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure. Timepoint: 14 days and 28 days after intervention and then monthly up to 6 month. Method of measurement: clinical examination.;Recurrence. Timepoint: 14 days and 28 days after intervention and then monthly up to 6 month. Method of measurement: clinical examination.
- Secondary Outcome Measures
Name Time Method